oral bpc 157 bioavailability study peptides in research: changes the game BPC-157 Oral vs Injection: Benefits,

The intestinal microbiota of IBD patients is characterized by an increase in pro-inflammatory bacteria and altered expression of multiple cytokines [95, 97, 98]

Due to the peptide compositions, AMPs are unfortunately limited in their potential to be used in vivo by a number of variables, including minimal tissue penetration, rapid removal from circulation, decreased bioavailability, limited stability, and low selectivity against bacterial cells relative to mammalian cells

Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, et al

This conversion is vital

Training history also plays a role, since years of flat bench focus can widen the difference between your two lifts